Equillium, Inc.

NASDAQ:EQ

Biotechnology

Healthcare
$1.12 +1.51%

+$0.05 today

Market cap
$92.20M
Beta
1.76
P/E (TTM)
-15.3
EPS (TTM)
-$0.20
52W Low $0.27High $3.45

Volume 0.60M

Average 0.60M

Income Statement

Follow revenue through to earnings.

Revenue

$0.00

FY 2025 · Annual

Operating Income

-$23.63M

FY 2025 · Annual

Net Income

-$22.40M

FY 2025 · Annual

Income Statement

USD
Metric
FY 2021
Dec 2021
FY 2022
Dec 2022
FY 2023
Dec 2023
FY 2024
Dec 2024
FY 2025
Dec 2025
Revenue015.76M36.08M41.1M0
Cost of Revenue0000116K
Gross Profit015.76M36.08M41.1M(116K)
Gross Margin—100.0%100.0%100.0%—
Research & Development26.38M37.55M37.04M37.43M12.84M
Selling, General & Admin11.41M17.24M13.57M11.94M10.79M
Operating Expenses37.79M77.84M50.61M49.36M23.63M
Depreciation & Amortization72K118K126K137K116K
EBITDA(37.91M)(61.26M)(12.14M)(7.57M)(22.28M)
EBITDA Margin—-388.7%-33.6%-18.4%—
Operating Income(37.79M)(62.08M)(14.52M)(8.27M)(23.63M)
Operating Margin—-393.9%-40.2%-20.1%—
Interest Income57K420K2.33M1.38M833K
Interest Expense1.07M1.05M491K00
Other Income / Expenses(1.27M)(352K)1.77M563K1.24M
Income Before Tax(39.05M)(62.43M)(12.76M)(7.71M)(22.4M)
Pre-Tax Margin—-396.1%-35.3%-18.8%—
Income Tax Expense00580K361K0
Net Income(38.98M)(62.43M)(13.34M)(8.07M)(22.4M)
Net Margin—-396.1%-37.0%-19.6%—
EPS (Basic)(1.35)(3.19)(0.38)(0.23)(0.39)
EPS (Diluted)(1.35)(3.19)(0.38)(0.23)(0.39)
Weighted Avg Shares28.81M33.73M34.73M35.36M91.88M
Weighted Avg Shares (Diluted)28.81M33.73M34.73M35.36M91.88M

EQ Earnings Waterfall · TTM

NASDAQ:EQ · Revenue to Net Income

Key Ratios

EPS$-0.38
Gross Margin0.0%
Net Margin0.0%
P/E Ratio-5.5
P/S Ratio0.0

Analysis

$0 of revenue converted into -$19.1M of net income for the selected period. Gross margin is 0.0% and net margin is 0.0%, showing how much revenue survives after costs and taxes. EPS is $-0.38, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13G/ASC 13G/A filingNov 13, 2026
S-3S-3 filingNov 12, 2026
10-QQuarterly reportNov 12, 2026
8-KCurrent reportNov 12, 2026
SC 13G/ASC 13G/A filingNov 12, 2026

How much revenue does EQ generate?

Equillium, Inc. (EQ) reported $0.00 of revenue in fiscal 2025.

Is EQ profitable?

Equillium, Inc. (EQ) reported -$22.40M of net income.